From the best budget to the best vegan and toddler-friendly options, we tested over 50 shakes with experts to find our top picks for meal replacements.

Objectives This study describes the prototype testing and clinical validation of the Fit-Frailty App, a fully guided, interactive mobile health (mHealth) app to assess frailty and sarcopenia. This ...

Objective To examine whether a multicomponent commercial fitness app with very small (‘micro’) financial incentives (FI) ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

When AI-assisted coding is 20% slower and almost half of it introduces Top 10-level threats, it’s time to make sure we're not ...

Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...

Conclusions: Two-stage HRSN screening based on geography is suboptimal. Although a 2-stage approach based on area-level socioeconomic measures can reduce the number of patients requiring ...

Market forecasters project the CAR-T cell therapy market will surge from $3.87 billion in 2024 to $13.25 billion by 2030, driven by unprecedented efficacy in relapsed and refractory patient ...

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the publication of two back-to-back papers in Spine detailing 24-month ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

In addition, Tenax announced today it will initiate a global, multi-center, long-term, open-label extension (OLE) study. The OLE study will provide patients enrolled in levosimendan clinical trials ...

Next Level Baker is an all-new, three-week special event series that premiered on Thursday, December 4, at 9 p.m. ET/PT on Fox. Culinary genius Gordon Ramsay is the host of the three-week holiday ...